📈 Fed's first cut since 2020: Time to buy the dip? See Tech-focused stock picksUnlock AI Picks

Prescient Therapeutics Ltd (PTX)

Sydney
Currency in AUD
Disclaimer
0.041
0.000(0.00%)
Closed
PTX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
0.0400.041
52 wk Range
0.0370.105
Bid/Ask
0.044 / 0.041
Prev. Close
0.041
Open
0.041
Day's Range
0.04-0.041
52 wk Range
0.037-0.105
Volume
263,224
Average Volume (3m)
639,057
1-Year Change
-38.35%
Fair Value
Unlock
Fair Value Upside
Unlock
PTX Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year
Show more

Prescient Therapeutics Ltd Company Profile

Prescient Therapeutics Limited, a clinical stage oncology company, develops drugs for the treatment of various cancers in Australia. Its lead drug candidate is PTX-100, a first in class compound with the ability to block an cancer growth enzyme, thereby disrupting the oncogenic Ras pathway. The company was formerly known as Virax Holdings Limited and changed its name to Prescient Therapeutics Limited in December 2014. Prescient Therapeutics Limited was incorporated in 1986 and is based in Melbourne, Australia.

Compare PTX to Peers and Sector

Metrics to compare
PTX
Peers
Sector
Relationship
P/E Ratio
−4.0x−3.4x−0.6x
PEG Ratio
0.64−0.020.00
Price/Book
1.8x4.8x2.6x
Price / LTM Sales
8.9x9.9x3.1x
Upside (Analyst Target)
240.2%156.8%55.8%
Fair Value Upside
Unlock−2.5%7.3%Unlock

FAQ

What Is the Prescient Therapeutics Ltd (PTX) Stock Price Today?

The Prescient Therapeutics Ltd stock price today is 0.041

What Stock Exchange Does Prescient Therapeutics Ltd Trade On?

Prescient Therapeutics Ltd is listed and trades on the Sydney stock exchange.

What Is the Stock Symbol for Prescient Therapeutics Ltd?

The stock symbol for Prescient Therapeutics Ltd is "PTX."

What Is the Prescient Therapeutics Ltd Market Cap?

As of today, Prescient Therapeutics Ltd market cap is 32.21M.

What is Prescient Therapeutics Ltd Earnings Per Share?

The Prescient Therapeutics Ltd EPS is -0.01.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.